HB 1927 prohibits Missouri health insurance plans from requiring prior authorization (pre-approval) for inpatient psychiatric hospital services. This bill directly affects patients seeking psychiatric hospitalization and health insurers who currently must approve such care before coverage. The key provision removes the requirement for insurers to review and approve inpatient psychiatric care in advance, streamlining access to treatment. It applies specifically to inpatient psychiatric hospital services, not other types of care or outpatient treatment. The bill repeals existing prior authorization rules for this service under Missouri law.
SB 1047 aims to establish new requirements for insurance coverage related to cancer treatment, directly affecting health insurance providers and patients seeking cancer care. The bill's official abstract indicates it will enact specific provisions governing coverage standards, though the context provided does not detail exact requirements (e.g., specific treatments, coverage limits, or timelines). As the bill is in early stages (prefiled, first reading), no concrete mechanisms or affected groups beyond insurers and cancer patients are described in the available information. Without additional details on the provisions, the summary cannot specify policy changes beyond the general intent stated in the title. For precise details, review the full bill text once introduced.
SB 1036 modifies Missouri's Missouri Works program, which provides tax incentives to businesses creating jobs. It redefines key terms like "average wage" (calculated using payroll and hours worked) and "county average wage" (using state data, with adjustments for relocating employees from higher-wage counties requiring community endorsements). The bill also specifies that "full-time employees" must work 35+ hours weekly and receive health insurance, and clarifies that "new capital investment" includes costs after program approval. These changes aim to standardize eligibility criteria and wage calculations for businesses seeking program benefits. The bill is currently under review by the Senate Government Efficiency Committee.
HB 2371 requires health insurance plans that cover maternity to include coverage for a home blood pressure monitoring device and related services (like training, data tracking, and provider review) for pregnant and postpartum women. This applies to plans issued, renewed, or continued in the state after January 1, 2027. The bill defines the device as a clinically validated mobile tool and specifies that "home blood pressure monitoring device services" include patient education, daily blood pressure tracking, and treatment adjustments based on data shared with providers. It directly affects pregnant and postpartum women enrolled in such health plans, ensuring they receive covered access to this monitoring tool and support. The law mandates this coverage as a specific benefit under maternity plans, effective in 2027.
HB 2296 requires health insurance plans in Missouri to cover nonopioid medications for acute pain without discrimination. It prohibits insurers from denying coverage for nonopioid drugs, forcing patients to try opioids first, or charging higher out-of-pocket costs for nonopioid options when prescribed by a licensed provider for pain expected to last 30 days or less. The law applies to all health benefit plans issued or renewed on or after January 1, 2027, directly affecting insurance companies and enrollees (policyholders) seeking pain treatment. This creates a clear standard for coverage of nonopioid alternatives to opioids for short-term pain management.
SB 1147 would establish new requirements for insurance plans to cover mental health treatments. It directly affects individuals with mental health conditions who rely on insurance for care, aiming to ensure comprehensive coverage. The bill, currently referred to the Senate Insurance and Banking Committee, proposes specific provisions for insurance coverage but does not detail exact mechanisms in the provided abstract. As a proposed policy change, it seeks to address gaps in mental health care access through insurance mandates.
SB 1449 would require health insurance plans to cover non-opioid alternatives for pain management, such as physical therapy or certain medications. This bill directly affects insurance companies, which would need to provide this coverage, and patients seeking pain treatment without opioids. The key provision mandates that insurers treat these non-opioid options with the same coverage terms as opioid medications. The bill aims to expand access to safer pain management options through insurance coverage.
HB 1966 requires health insurance plans in Missouri to cover nonopioid medications for acute pain (pain expected to last 30 days or less) on the same terms as opioids. It prohibits insurers from denying coverage for nonopioid drugs, forcing patients to try opioids first, or charging higher out-of-pocket costs for nonopioid options. The law directly affects patients (enrollees) and health insurance plans, ensuring equal treatment for nonopioid alternatives when prescribed by licensed providers. It takes effect for all new or renewed health benefit plans on or after January 1, 2027.
HB 1941 requires health insurance plans in Missouri to count payments for non-generic medications toward a patient's annual out-of-pocket maximum. Specifically, health carriers must include costs paid by enrollees for medications where a generic version is unavailable when calculating this limit. The bill also prohibits plans from adjusting cost-sharing requirements based on the availability of cost-assistance programs for such medications. This directly affects patients using non-generic prescription drugs who would otherwise face unexpectedly high out-of-pocket expenses. The law applies to most health benefit plans starting August 28, 2026.
SB 1113 requires health insurance plans to cover genetic screenings for hereditary cancer risk without cost-sharing (like copays or deductibles). It directly affects individuals with a family history of certain cancers who would otherwise face high out-of-pocket costs for these screenings. The key provision mandates that insurers include these screenings as a standard benefit in health plans, similar to other preventive services. This policy change ensures broader access to early detection tools for at-risk patients.
